EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients

TY - JOUR

T1 - EASI p-EASI

T2 - Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients

AU - Thijs, Judith L.

AU - Fiechter, Renée

AU - Bruijnzeel-Koomen, Catharina A.F.M.

AU - Knol, Edward F.

AU - Giovannone, Barbara

AU - de Bruin-Weller, Marjolein S.

AU - Hijnen, Dirk Jan

AU - Thijs, Judith L.

AU - Drylewicz, Julia

AU - Fiechter, Renée

AU - Nierkens, Stefan

AU - Hijnen, Dirk Jan

AU - Strickland, Ian

AU - Sleeman, Matthew A.

AU - Herath, Athula

AU - May, Richard D.

AU - Nierkens, Stefan

N1 - Funding Information: The study was supported in part by MedImmune. Funding Information: Disclosure of potential conflict of interest: I. Strickland and A. Herath are former employees of MedImmune. M. A. Sleeman was employed by MedImmune Ltd at the time of this study and previously held shares in AstraZeneca. R. D. May is employed by MedImmune and receives stock/stock options as part of his compensation. C. A. F. M. Bruijnzeel-Koomen has received grants from MedImmune and UMC Urtrecht (grant no. CW435174). M. S. de Bruin-Weller has board memberships with Regeneron/Sanofi and AbbVie, has consultant arrangements with Regeneron/Sanofi, and has received grants from Regeneron/Sanofi. D. J. Hijnen has received grants from MedImmune and UMC Urtrecht (grant no. CW435174) and Regeneron and is on advisory boards for MedImmune and Novartis. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2017/12/1

Y1 - 2017/12/1

UR - https://www.scopus.com/pages/publications/85029224607

U2 - 10.1016/j.jaci.2017.06.046

DO - 10.1016/j.jaci.2017.06.046

M3 - Article

C2 - 28823810

AN - SCOPUS:85029224607

SN - 0091-6749

VL - 140

SP - 1703

EP - 1705

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 6

ER -